Published in Ann Thorac Surg on January 01, 2004
Monitoring of the adult patient on venoarterial extracorporeal membrane oxygenation. ScientificWorldJournal (2014) 0.95
Extracorporeal membrane oxygenation using the TandemHeart System's catheters. Tex Heart Inst J (2009) 0.84
Effects of continuous renal replacement therapy on renal inflammatory cytokines during extracorporeal membrane oxygenation in a porcine model. J Cardiothorac Surg (2013) 0.84
Effects of intra-aortic balloon pump on cerebral blood flow during peripheral venoarterial extracorporeal membrane oxygenation support. J Transl Med (2014) 0.84
The use of extracorporeal membrane oxygenation in patients with therapy refractory cardiogenic shock as a bridge to implantable left ventricular assist device and perioperative right heart support. J Artif Organs (2009) 0.83
Results of extracorporeal life support implementation in routine clinical practice: single center experience. Croat Med J (2014) 0.81
Implantation of left ventricular assist devices under extracorporeal life support in patients with heparin-induced thrombocytopenia. J Artif Organs (2015) 0.80
Is there an association between hyperglycemia and clinical outcome in adult patients receiving extracorporeal membrane oxygenation. J Extra Corpor Technol (2010) 0.80
Outcome of veno-arterial extracorporeal membrane oxygenation for patients undergoing valvular surgery. PLoS One (2013) 0.80
Factors influencing the outcome of paediatric cardiac surgical patients during extracorporeal circulatory support. J Cardiothorac Surg (2007) 0.79
Extracorporeal cardiopulmonary resuscitation for adult patients who underwent post-cardiac surgery. Eur J Med Res (2015) 0.79
[Percutaneous extracorporeal life support in acute severe hemodynamic collapses: single centre experience in 100 consecutive patients]. Can J Cardiol (2009) 0.79
Advanced mechanical circulatory support for post-cardiotomy cardiogenic shock: a 20-year outcome analysis in a non-transplant unit. J Cardiothorac Surg (2016) 0.78
Extracorporeal membrane oxygenation in severe acute respiratory failure in postpartum woman with rheumatic mitral valve disease: benefit, factors furthering the success of this procedure, and review of the literature. J Extra Corpor Technol (2007) 0.77
Outcome of veno-venous extracorporeal membrane oxygenation use in acute respiratory distress syndrome after cardiac surgery with cardiopulmonary bypass. J Thorac Dis (2016) 0.76
A 20-year multicentre outcome analysis of salvage mechanical circulatory support for refractory cardiogenic shock after cardiac surgery. J Cardiothorac Surg (2016) 0.75
Heparin-coated adult ECMO vs. ventricular assist devices: a decision analysis modeling approach. J Extra Corpor Technol (2006) 0.75
Extracorporeal membrane oxygenation with hemoconcentration: in a hypervolemic patient with critical aortic stenosis. Tex Heart Inst J (2011) 0.75
The Complex Relationship of Extracorporeal Membrane Oxygenation and Acute Kidney Injury: Causation or Association? Biomed Res Int (2016) 0.75
Coagulation Parameter Thresholds Associated with Non-Bleeding in the Eighth Hour of Adult Cardiac Surgical Post-Cardiotomy Extracorporeal Membrane Oxygenation. J Extra Corpor Technol (2016) 0.75
Use of a fixed, body weight-unadjusted loading dose of unfractionated heparin for extracorporeal cardiopulmonary resuscitation. J Intensive Care (2015) 0.75
How to improve flow during cardiopulmonary bypass in an acardia experimental model. Interact Cardiovasc Thorac Surg (2012) 0.75
Extra-corporeal membrane oxygenation for the post-cardiotomy patient. Heart Fail Rev (2014) 0.75
Experience with Mechanical Circulatory Support for Medically Intractable Low Cardiac Output in a Pediatric Intensive Care Unit. Korean Circ J (2017) 0.75
[Use of ECMO in adult patients with cardiogenic shock: a position paper of the Austrian Society of Cardiology]. Wien Klin Wochenschr (2015) 0.75
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med (2009) 17.17
Comparison of stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery. N Engl J Med (2002) 5.24
The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention (2005) 5.16
Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A (2003) 5.08
Esophageal perforation during left atrial radiofrequency ablation: Is the risk too high? J Thorac Cardiovasc Surg (2003) 4.03
Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol (2007) 3.82
Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation (2010) 3.79
Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J (2011) 3.29
Minimally invasive hybrid coronary artery revascularization. Ann Thorac Surg (2008) 2.79
Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. Ann Thorac Surg (2003) 2.72
Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N Engl J Med (2011) 2.65
Predictors of delirium after cardiac surgery delirium: effect of beating-heart (off-pump) surgery. J Thorac Cardiovasc Surg (2004) 2.59
Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation (2007) 2.58
The frozen elephant trunk for the treatment of chronic dissection of the thoracic aorta: a multicenter experience. Ann Thorac Surg (2011) 2.51
Minimally invasive mitral valve surgery is a very safe procedure with very low rates of conversion to full sternotomy. Eur J Cardiothorac Surg (2012) 2.42
Minimally invasive mitral valve surgery after previous sternotomy: experience in 181 patients. Ann Thorac Surg (2009) 2.42
Transapical aortic valve implantation: step by step. Ann Thorac Surg (2009) 2.31
Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol (2010) 2.24
Assessment of the SYNTAX score in the Syntax study. EuroIntervention (2009) 2.24
Surgical experience with 77 primary cardiac tumors. Interact Cardiovasc Thorac Surg (2005) 2.23
Prospective evaluation of consultant surgeon sleep deprivation and outcomes in more than 4000 consecutive cardiac surgical procedures. Arch Surg (2011) 2.12
Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg (2008) 2.06
Facilitated minimally invasive left ventricular epicardial lead placement. Ann Thorac Surg (2005) 2.05
What is the best strategy for brain protection in patients undergoing aortic arch surgery? A single center experience of 636 patients. Ann Thorac Surg (2012) 1.99
Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. J Am Coll Cardiol (2011) 1.98
One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation (2011) 1.98
Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves. JACC Cardiovasc Interv (2011) 1.94
Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur J Cardiothorac Surg (2008) 1.84
How does the use of polytetrafluoroethylene neochordae for posterior mitral valve prolapse (loop technique) compare with leaflet resection? A prospective randomized trial. J Thorac Cardiovasc Surg (2008) 1.80
A propensity score-adjusted retrospective comparison of early and mid-term results of mitral valve repair versus replacement in octogenarians. Eur Heart J (2010) 1.78
Learning minimally invasive mitral valve surgery: a cumulative sum sequential probability analysis of 3895 operations from a single high-volume center. Circulation (2013) 1.78
Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data. Eur J Cardiothorac Surg (2011) 1.77
Comprehensive assessment of frailty for elderly high-risk patients undergoing cardiac surgery. Eur J Cardiothorac Surg (2011) 1.76
Experience with the conventional and frozen elephant trunk techniques: a single-centre study. Eur J Cardiothorac Surg (2013) 1.73
Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial. Catheter Cardiovasc Interv (2011) 1.71
Palliation and survival after repeated (188)Re-HEDP therapy of hormone-refractory bone metastases of prostate cancer: a retrospective analysis. J Nucl Med (2011) 1.69
Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients. J Clin Oncol (2006) 1.68
Visceral arterial compromise during intra-aortic balloon counterpulsation therapy. Circulation (2010) 1.68
Transgenic rat model of Huntington's disease. Hum Mol Genet (2003) 1.66
Ablation of atrial fibrillation and esophageal injury: effects of energy source and ablation technique. J Thorac Cardiovasc Surg (2005) 1.65
Minimal invasive mitral valve repair for mitral regurgitation: results of 1339 consecutive patients. Eur J Cardiothorac Surg (2008) 1.65
Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg (2010) 1.62
Automated coring and apical connector insertion device for aortic valve bypass surgery. Ann Thorac Surg (2012) 1.62
Human minimally invasive off-pump valve-in-a-valve implantation. Ann Thorac Surg (2008) 1.60
Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circ Res (2008) 1.59
High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study. Ann Intern Med (2002) 1.58
G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation (2005) 1.57
Mitral valve surgical procedures in the elderly. Ann Thorac Surg (2012) 1.57
Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure. Cardiovasc Res (2009) 1.57
Reduced hypertension-induced end-organ damage in mice lacking cardiac and renal angiotensinogen synthesis. J Mol Med (Berl) (2002) 1.54
Single-stage hybrid coronary revascularization with long-term follow-up. Eur J Cardiothorac Surg (2013) 1.54
Transapical double valve implantation plus percutaneous revascularization as a bailout for a high-risk patient. J Thorac Cardiovasc Surg (2012) 1.52
Immediate primary transcatheter closure of postinfarction ventricular septal defects. Eur Heart J (2008) 1.51
A second prosthesis as a procedural rescue option in trans-apical aortic valve implantation. Eur J Cardiothorac Surg (2011) 1.50
Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons. Circ Cardiovasc Qual Outcomes (2012) 1.50
Twelve-month patency with the PAS-port proximal connector device: a single center prospective randomized trial. Ann Thorac Surg (2008) 1.50
Transapical aortic valve implantation: therapy of choice for patients with aortic stenosis and porcelain aorta? Ann Thorac Surg (2010) 1.49
Does the trainee's level of experience impact on patient safety and clinical outcomes in coronary artery bypass surgery? J Card Surg (2008) 1.49
Cardio navigation: planning, simulation, and augmented reality in robotic assisted endoscopic bypass grafting. Ann Thorac Surg (2005) 1.48
Transapical aortic valve implantation in patients requiring redo surgery. Eur J Cardiothorac Surg (2009) 1.47
Value of augmented reality-enhanced transesophageal echocardiography (TEE) for determining optimal annuloplasty ring size during mitral valve repair. Ann Thorac Surg (2008) 1.47
Patient prosthesis mismatch affects short- and long-term outcomes after aortic valve replacement. Eur J Cardiothorac Surg (2006) 1.46
Significant value of autopsy for quality management in cardiac surgery. J Thorac Cardiovasc Surg (2005) 1.45
3D-Imaging of cardiac structures using 3D heart models for planning in heart surgery: a preliminary study. Interact Cardiovasc Thorac Surg (2007) 1.45
Minimally invasive transapical beating heart aortic valve implantation--proof of concept. Eur J Cardiothorac Surg (2006) 1.45
Effect of preoperative statin therapy on patients undergoing isolated and combined valvular heart surgery. Ann Thorac Surg (2010) 1.44
Brain natriuretic peptide as a predictor of cardiomyopathy in Chagas' disease. Lancet (2003) 1.43
Cognitive decline and ischemic microlesions after coronary catheterization. A comparison to coronary artery bypass grafting. Am Heart J (2011) 1.43
Selective cerebral perfusion using moderate flow in complex cardiac surgery provides sufficient neuroprotection. Are children young adults? Eur J Cardiothorac Surg (2012) 1.43
Chordae replacement versus resection for repair of isolated posterior mitral leaflet prolapse: à ègalité. Ann Thorac Surg (2009) 1.43
One-year outcomes of the Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve (TRITON) trial: a prospective multicenter study of rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve System. J Thorac Cardiovasc Surg (2012) 1.43
Worldwide experience with the 29-mm Edwards SAPIEN XT™ transcatheter heart valve in patients with large aortic annulus. Eur J Cardiothorac Surg (2012) 1.42
Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease. JACC Cardiovasc Interv (2013) 1.42
Immunoglobulin G treatment of postcardiac surgery patients with score-identified severe systemic inflammatory response syndrome--the ESSICS study. Crit Care Med (2008) 1.42
Extracorporeal membrane oxygenation: experience in acute graft failure after heart transplantation. Clin Transplant (2014) 1.42
Comparison of outcomes of minimally invasive mitral valve surgery for posterior, anterior and bileaflet prolapse. Eur J Cardiothorac Surg (2009) 1.41
Massive cerebral air embolism after bronchoscopy and central line manipulation. Asian Cardiovasc Thorac Ann (2009) 1.41
Long-term prognosis of type A aortic dissection in non-Marfan patients with histologic pattern of cystic medial necrosis. Ann Thorac Surg (2008) 1.40
No-touch aorta off-pump coronary bypass operation: arteriovenous composite grafts may be used as a last resort. Ann Thorac Surg (2013) 1.39
Prognostic significance of circulating levels of hepatocyte growth factor in patients with chagas' disease and idiopathic dilated cardiomyopathy. Cardiology (2012) 1.39
Transapical aortic valve implantation off-pump in patients with impaired left ventricular function. Ann Thorac Surg (2011) 1.39
Execution of the meiotic noncoding RNA expression program and the onset of gametogenesis in yeast require the conserved exosome subunit Rrp6. Proc Natl Acad Sci U S A (2010) 1.39
Catheter-based endoscopic bypass grafting: an experimental feasibility study. Ann Thorac Surg (2007) 1.39
Aortic valve replacement in octogenarians: utility of risk stratification with EuroSCORE. Ann Thorac Surg (2009) 1.32